Melatonin for Sleep: Dosage, Timing, and What Actually Works

Most people who take melatonin are doing it wrong. Not in a dangerous way. Just in a way that explains why it often does not do much.

The standard advice is to take 0.5 to 1 mg thirty minutes before bed. A 2024 meta-analysis of 26 randomized controlled trials suggests that advice gets both the dose and the timing wrong for most adults.

Here is what the research actually shows, what melatonin can and cannot do, and how to use it if you are going to use it at all.

What This Page Covers

• How melatonin works in the brain
• What the 2024 dose-response meta-analysis found
• Why timing matters more than most people realize
• When melatonin is the right tool and when it is not
• The FDA oversight gap and labeling accuracy problems
• How melatonin fits into a broader sleep and mental health picture

How Melatonin Works

Melatonin is a hormone produced primarily in the pineal gland in response to darkness. Its job is to signal to the brain and body that night has arrived and sleep should begin. It does not sedate you directly. It shifts the timing of your circadian clock.

Endogenous melatonin is a naturally produced hormone primarily synthesized and secreted in the pineal gland. Melatonin regulates the body’s sleep-wake cycles by interacting with the suprachiasmatic nucleus of the hypothalamus and the retina through its MT1 and MT2 receptors. The suprachiasmatic nucleus is the brain’s master clock.

When you take exogenous melatonin, the supplement mimics this signal. For people whose clock is running late, specifically those with delayed sleep phase disorder, or those whose clock has been disrupted by travel, shift work, or light exposure, this supplemental signal can bring sleep onset forward.

For people whose insomnia is driven by anxiety, learned arousal, or behavioral patterns, melatonin does very little because those factors are not circadian in origin.

What the 2024 Research Found

A 2024 systematic review and dose-response meta-analysis published in the Journal of Pineal Research analyzed 26 double-blind randomized controlled trials with 1,689 observations. The findings challenge standard clinical guidance on both dose and timing.

According to PubMed, melatonin gradually reduces sleep onset latency and increases total sleep time, with effects peaking at 4 mg per day. The standard clinical advice to start with 0.5 to 1 mg and take it 30 minutes before bed was found to be suboptimal on both counts.

The analysis found that advancing the timing of administration, specifically administering melatonin 3 hours before the desired bedtime rather than 30 minutes before, and increasing the dose to 4 mg, might optimize the efficacy of exogenous melatonin in promoting sleep. This does not mean everyone should immediately move to 4 mg. But it does mean the common advice to start low and take it just before bed may not produce the results people hope for.

The same analysis confirmed that melatonin is more effective in healthy volunteers with normal sleep architecture than in people with clinical insomnia, and that later administration relative to bedtime consistently reduces effectiveness.

Dose: What Is Actually Known

The gap between common clinical practice and research findings on dosage is notable.

Most commercially available melatonin in the United States comes in 3 mg, 5 mg, and 10 mg formulations, even though the research basis for doses above 4 mg is thin. High doses do not produce proportionally better sleep. They are more likely to produce next-day grogginess, disrupted sleep architecture in the second half of the night, and may blunt the body’s own melatonin signal over time.

For most adults beginning melatonin:

• Start with 0.5 to 1 mg if your goal is circadian adjustment (jet lag, delayed sleep phase)
• For sleep onset specifically, the 2024 data suggests 2 to 4 mg administered earlier than most people take it may be more effective
• Exceeding 5 mg per night without clinical guidance is unlikely to help and may cause side effects

The Sleep Foundation’s recommended range of 1 to 5 mg reflects clinical consensus, though individual response varies significantly based on age, body weight, and the specific sleep problem being addressed.

Timing: The Factor Most People Get Wrong

The circadian biology here matters. Melatonin works by shifting the clock, not by putting you to sleep. Taking it 30 minutes before bed means it arrives around the time your body is already beginning its natural melatonin rise. You are not advancing your clock. You are just adding to a signal that is already occurring.

Taking melatonin 2 to 3 hours before your desired bedtime gives it time to shift the clock forward, so that your body’s sleep drive arrives earlier than it naturally would. For delayed sleep phase disorder, this is the mechanism that actually works.

The AASM supports melatonin treatment for delayed sleep-wake phase disorder in adults, with administration timed to advance the circadian phase, not simply to provide sedation near bedtime.

For jet lag, timing shifts relative to your destination time zone rather than your home clock. Travelers crossing eastward across up to seven time zones are typically advised to take 0.5 to 3 mg around bedtime in the destination time zone after arrival.

What Melatonin Cannot Do

This is the most important part of the evidence.

Both the American Academy of Sleep Medicine and the American College of Physicians concluded there is insufficient evidence to recommend melatonin for chronic insomnia. Chronic insomnia, defined as difficulty falling or staying asleep at least three nights per week for three or more months, has psychological and behavioral drivers that melatonin cannot address. Conditioned arousal, sleep anxiety, hyperactivation of the stress response, and learned patterns of lying awake all require cognitive and behavioral interventions.

Cognitive behavioral therapy for insomnia (CBT-I) targets these mechanisms directly and produces remission rates of 70 to 80% in clinical trials, far exceeding what melatonin achieves even in optimal conditions. CBT-I is the first-line treatment for chronic insomnia, according to both the AASM and the American College of Physicians.

If you have been taking melatonin regularly for more than a few weeks without meaningful improvement, the problem is likely not your dose or timing. It is that melatonin is the wrong tool for what you are experiencing.

The Labeling Accuracy Problem

In the United States, melatonin is sold as a dietary supplement and is therefore not subject to the same rigorous standards as pharmaceutical drugs by the FDA. This has real consequences.

The majority of melatonin products do not contain the advertised dosage. Tests have revealed some products have significantly less melatonin than stated on the label, while others contain more than four times the advertised amount. This means that a labeled 1 mg tablet could contain anywhere from a fraction of a milligram to several milligrams.

Practical guidance: look for products with US Pharmacopeia (USP) certification, which verifies that the product has been tested by an independent organization for potency and purity. Ask your pharmacist or prescriber for a trusted brand if you are unsure.

Melatonin and Mental Health

The connection between melatonin and psychiatric conditions runs in multiple directions.

Sleep disruption is one of the most reliable early warning signs of mood episodes in people with depression or bipolar disorder. Circadian rhythm dysregulation, the same underlying mechanism that melatonin addresses, is implicated in major depression, bipolar disorder, and anxiety. Treating sleep disruption can therefore be an important component of psychiatric stability.

If insomnia persists despite melatonin therapy, consulting a psychiatrist to explore potential underlying disorders is recommended. A prescriber who can see the full clinical picture, including sleep patterns, mood trajectory, and medication interactions, can determine whether sleep disruption is a primary problem or a symptom of something that needs more comprehensive management.

“Sleep and psychiatric stability are deeply connected,” says Daniel Montville, MD, Psychiatrist, of the SiggyMD clinical team. “When a patient’s sleep is deteriorating, I want to know whether that is driven by anxiety, early depression, circadian disruption, or something behavioral. Melatonin has a role in the circadian piece. But giving melatonin to someone whose insomnia is driven by anxiety and not addressing the anxiety is treating the wrong thing.”

What Members Are Saying

MW

M.W., 38

Delayed Sleep Phase Disorder

“I had been trying to take melatonin for years with almost no effect. My prescriber told me I was taking it too late and at too low a dose. Switching to 2 mg taken two hours before the time I actually wanted to fall asleep made a noticeable difference within a week. I hadn’t realized timing mattered that much.”

TJ

T.J., 52

Insomnia with Anxiety

“I tried melatonin for three months and it didn’t touch my insomnia. My care team eventually realized the issue was my anxiety, not my circadian rhythm. Once we addressed the anxiety with therapy and medication, my sleep improved without melatonin. It wasn’t the tool I needed.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. SiggyMD is currently invite-only.

The Bottom Line

Melatonin works when it is used for the right problem at the right time and dose. For jet lag, shift work, and delayed sleep phase disorder, it is a reasonable and reasonably effective intervention. For chronic insomnia, it is largely the wrong tool. CBT-I is the standard of care.

If you are using melatonin and not seeing results, evaluating whether you have the right timing and dose is a reasonable starting point. But also consider whether chronic anxiety or another psychiatric condition is driving your sleep problems. That distinction matters for what gets treated.

To understand how sleep and anxiety interact and what treatment options look like for comorbid presentations, read our guide to how anxiety medications work and what to expect from them, or start your anonymous intake with SiggyMD to connect with a licensed prescriber who can evaluate your full sleep and mental health picture.

Sources

1. Cruz-Sanabria F, et al. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis. Journal of Pineal Research. 2024;76(5):e12985.

2. Patel AK, et al. Melatonin. StatPearls. NCBI Bookshelf. Updated February 2024.

3. Sleep Foundation. Melatonin Dosage: How Much Should I Take? Accessed June 2026.

4. Sleep Foundation. Melatonin: Usage, Side Effects, and Safety. Accessed June 2026.

5. Swanson L, et al. Low-dose exogenous melatonin plus evening dim light and time in bed scheduling advances circadian phase irrespective of measured or estimated dim light melatonin onset time. J Clin Sleep Med. 2024;20:1131-1140.

6. National Center for Complementary and Integrative Health (NCCIH). Melatonin: What You Need to Know. Accessed June 2026.

7. American Academy of Sleep Medicine. Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders. J Clin Sleep Med. 2015;11(10):1199-1236.

Reviewed by Daniel Montville, MD, Psychiatrist | Last updated June 2026